enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. GLP-1 Medications Reduce Alcohol Cravings, Per a New Study

   www.aol.com/glp-1-medications-reduce-alcohol...

   A study published in November found that people with alcohol-use disorder who took a GLP-1 receptor agonist medication were less likely to be hospitalized for alcohol-related issues.

3. Alprazolam - Wikipedia

   en.wikipedia.org/wiki/Alprazolam

   Benzodiazepines require special precaution if used in children and in alcohol- or drug-dependent individuals. Particular care should be taken in pregnant or elderly people, people with substance use disorder history, particularly alcohol dependence , and people with comorbid psychiatric disorders .

4. Naltrexone - Wikipedia

   en.wikipedia.org/wiki/Naltrexone

   Naltrexone, sold under the brand name Revia among others, is a medication primarily used to manage alcohol use or opioid use disorder by reducing cravings and feelings of euphoria associated with substance use disorder. [8]

5. Acamprosate - Wikipedia

   en.wikipedia.org/wiki/Acamprosate

   Acamprosate is a medication that works in the brain to treat alcohol use disorder. Acamprosate works by decreasing cravings and urges to use alcohol. This allows people who take the medication to control urges to drink and help to continue to not use alcohol. Acamprosate does not help with symptoms of alcohol withdrawal.

6. New treatments are needed for alcohol addiction. Are drugs ...

   www.aol.com/treatments-needed-alcohol-addiction...

   “The number of people with alcohol use disorder who receive an FDA-approved medication for alcohol use disorder in the United States is 2%,” he said. “My hope is that in addition to moving ...

7. Low-dose naltrexone - Wikipedia

   en.wikipedia.org/wiki/Low-dose_naltrexone

   Naltrexone is approved by the Food and Drug Administration (FDA) for medication-assisted treatment of alcoholism and opioid use disorders. [3] Bernard Bihari's initial off-label usage of naltrexone in doses ranging from 1.5 mg to 3 mg as an adjuvant therapy for acquired immune deficiency syndrome (AIDS) in the 1980s led to the introduction of ...